July 21, 2016
A Massachusetts federal judge trimmed some state-based claims against Warner Chilcott Ltd. and reverse-payment claims against it and generics maker Zydus Pharmaceuticals USA Inc. in a putative antitrust class action over a drug for ulcerative colitis, but left product-hopping claims intact.